Fluoroethylnormemantine

N/A

Report date: 2024/09/06 11:05:28
NME

Base Information

Drug NameFluoroethylnormemantine
Drug Alias NameRST-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesReST Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReST Therapeutics SAS
Active IndicationsN/A
Inactive IndicationsStress Disorders, Post-TraumaticDepressive Disorder, Treatment-ResistantDepressive Disorder, Major +[6] 

Other Information

ATC CodeN/A
Related LinksN/A